0001246360-17-002524.txt : 20170808
0001246360-17-002524.hdr.sgml : 20170808
20170808183511
ACCESSION NUMBER: 0001246360-17-002524
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170807
FILED AS OF DATE: 20170808
DATE AS OF CHANGE: 20170808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Turk Joseph E Jr
CENTRAL INDEX KEY: 0001341403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51567
FILM NUMBER: 171016034
MAIL ADDRESS:
STREET 1: NXSTAGE MEDICAL INC
STREET 2: 439 SOUTH UNION STREET 5TH FLOOR
CITY: LAWRENCE
STATE: MA
ZIP: 01843
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NxStage Medical, Inc.
CENTRAL INDEX KEY: 0001333170
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 043454702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 MERRIMACK STREET
CITY: LAWRENCE
STATE: MA
ZIP: 01843
BUSINESS PHONE: 978-687-4700
MAIL ADDRESS:
STREET 1: 350 MERRIMACK STREET
CITY: LAWRENCE
STATE: MA
ZIP: 01843
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2017-08-07
false
0001333170
NxStage Medical, Inc.
NXTM
0001341403
Turk Joseph E Jr
350 MERRIMACK STREET
LAWRENCE
MA
01843
false
true
false
false
President
Common Stock
2017-08-07
4
M
false
7000
11.03
A
82903
D
Common Stock
2017-08-07
4
M
false
12000
14.66
A
94903
D
Common Stock
2017-08-07
4
M
false
2669
18.48
A
97572
D
Common Stock
2017-08-07
4
M
false
2331
18.59
A
99903
D
Common Stock
2017-08-07
4
S
false
6000
29.66
D
93903
D
Common Stock
2017-08-07
4
S
false
18000
29.63
D
75903
D
Stock Option (Right to Buy)
11.03
2017-08-07
4
M
false
7000
0
D
2013-04-04
2023-03-03
Common Stock
7000
25897
D
Stock Option (Right to Buy)
14.66
2017-08-07
4
M
false
12000
0
D
2014-04-10
2024-03-09
Common Stock
12000
36958
D
Stock Option (Right to Buy)
18.48
2017-08-07
4
M
false
2669
0
D
2012-04-09
2019-03-08
Common Stock
2669
7542
D
Stock Option (Right to Buy)
18.59
2017-08-07
4
M
false
2331
0
D
2011-06-27
2018-05-26
Common Stock
2331
5392
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016.
/s/ Aras Lapinskas, attorney-in-fact for Joseph Turk
2017-08-08